LS CANCERDIAG OY
LS CancerDiag Ltd is committed to reducing cancer mortality rates with an efficient, simple diagnostic method that detects an inherited cancer-causing condition prior to cancer. Their vision is to see DiagMMRâ„¢ as a new global testing standard in LS diagnostics. Lynch syndrome is the main cause of hereditary colorectal cancers and it also causes a broad spectrum of other tumors. With a significant proportion of the world’s population carrying the Lynch syndrome mutation, there are potentiall... y tens of millions under a severe risk for being affected by LS. Their groundbreaking DiagMMRâ„¢ assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome (previously known as Hereditary NonÂPolyposis Colorectal Cancer; HNPCC). Their mission is to save lives through an innovation that dramatically simplifies diagnostics of Lynch syndrome by delivering predictive and accurate results with a fast, unique and cost-efficient method globally.
LS CANCERDIAG OY
Industry:
Bioinformatics Health Care Health Diagnostics
Founded:
2013-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.lscancerdiag.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Corscans
CorScans is a healthcare organization that operates a healthcare platform that bridges the gap between doctors and their patients.
Lenus Health
Lenus uses patient-generated healthcare data to reduce wait times and rehospitalisation rates while empowering patients and improving care.
Current Employees Featured
Founder
Investors List
StartUp Health
StartUp Health investment in Seed Round - LS CancerDiag Oy
Official Site Inspections
http://www.lscancerdiag.com Semrush global rank: 9.46 M Semrush visits lastest month: 154
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LS CancerDiag Oy"
LS CancerDiag Oy - Crunchbase Company Profile & Funding
Organization. LS CancerDiag Oy . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. LS CancerDiag Ltd is committed to …See details»
LS CancerDiag: Contact Details and Business Profile
Lscancerdiag.com; organi.health; 4 4176430XXXX; 5198900XXXX; 511745XXXX; 35846583XXXX; Maria Korkala Administrative Specialist at LS CancerDiag Helsinki, FI View. …See details»
LS CancerDiag - VentureRadar
Open PageRank: 7,081,696 | lscancerdiag.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times …See details»
Lynsight - The Hub
Lynsight (formerly LS CancerDiag) has developed DiagMMR, a unique predictive diagnostic test to detect Lynch syndrome. We provide easily interpretable and …See details»
LS CancerDiag - LinkedIn
LS CancerDiag | 644 followers on LinkedIn. Detect Lynch syndrome - prevent cancer | LS CancerDiag Ltd is committed to reducing cancer mortality rates with a simple diagnostic …See details»
LS CancerDiag Overview | SignalHire Company Profile
Organization Website: lscancerdiag.com : LS CancerDiag industries Medtech: Headquarters Location: Arabiankatu 12, Helsinki, Uusimaa, 00560 FI Arabiankatu 12, Helsinki, U... LS …See details»
Lynsight - yritystiedot, päättäjät, taloustiedot | Finder
Www.lscancerdiag.com. Lisää suosikkeihin compare_arrows Lisää vertailuun share Jaa sivu. Liikevaihto tuhatta euroa. 2023. Tilikauden tulos miljoonaa euroa. −612,45 % 2023. Vertaa …See details»
LS CancerDiag - Company Information, Competitors, News & FAQs
Find useful insights on LS CancerDiag's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at LS CancerDiag.See details»
LS CancerDiag Oy - Drug pipelines, Patents, Clinical trials - Synapse
Explore LS CancerDiag Oy with its drug pipeline, therapeutic area, technology platform, .See details»
LS CancerDiag - Overview, News & Similar companies - ZoomInfo
View LS CancerDiag (www.lscancerdiag.com) location in Uusimaa, Finland , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
LS CancerDiag - VentureRadar
Website: http://lscancerdiag.com. Offers DiagMMR®, a unique test for early and precise detection of Lynch syndrome, facilitating personalized care and reducing ...See details»
LS CancerDiag Oy - Funding, Financials, Valuation & Investors
Apr 8, 2016 Organization. LS CancerDiag Oy . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 1. …See details»
LS CancerDiag on LinkedIn: Introducing the newest LS CancerDiag …
To reach our vision of becoming the global leader for Lynch syndrome diagnostics, we strive to build a team that brings together the field’s top researchers and experienced healthcare …See details»
LS CancerDiag - Cision News
LS CancerDiag Ltd is a company committed to reducing cancer mortality rates with a low-cost, comprehensive diagnostic method that detects an inherited cancer-causing deficiency prior to …See details»
LS CancerDiag - Products, Competitors, Financials, Employees ...
Aug 10, 2023 Altitude Marketing Announces Branding & Marketing Partnership with LS CancerDiag. Aug 10, 2023. News provided by Share this article Share toX Altitude Marketing, …See details»
LSCD Industry Symposium - Lynsight - LS CancerDiag
Oct 17, 2023 Welcome to the LS CancerDiag Industry Symposium at the 2023 CGA-IGC Annual Meeting!See details»
LS CancerDiag Oy - Contacts, Employees, Board Members
LS CancerDiag Ltd is committed to reducing cancer mortality rates with an efficient, simple diagnostic method.See details»
LS CancerDiag Receives Patent For Revolutionary Predictive Cancer ...
Oct 15, 2015 HELSINKI, Finland--(BUSINESS WIRE)--Developed by Finnish company LS CancerDiag Ltd, the groundbreaking diagnostics innovation, DiagMMRâ„¢, method for early …See details»
LS CancerDiag on LinkedIn: Meet our CSO, Dr. Minttu Kansikas
As our team member head into their well-deserved holiday season, we'd like to share some background about one of them in our series that will continue…See details»
LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in ...
Apr 21, 2025 The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your …See details»